TP53 and cardiac hypertrophy: Work from our group has shown that cardiac-specific conditional co-deletion of p53 and Mdm2 (DKO) in adult mice led to downregulation of cardiac gene expression and the development of a dilated cardiomyopathy, in the absence of cardiac hypertrophy [77] with alterations in miRNA expression.